Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2025 | Addressing challenges in equal access to radiotherapy in lung cancer

May Abdel-Wahab, MD, PhD, International Atomic Energy Agency, Vienna, Austria, discusses the importance of radiotherapy in cancer treatment, where it is utilized in approximately half of all cancer cases. Dr Abdel-Wahab also emphasizes the need to address equity, availability, and access to advanced radiotherapy technologies, including machines and personnel, as well as the challenges that come with implementing these technologies. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

What we’re going to talk about is the use of advanced technologies in radiotherapy. And as you know, radiotherapy, 50% of all cancer patients need radiotherapy. It has a very important role both in early and more advanced lung cancer and other types of cancer. So this particular talk is going to look at equity and availability and access, and we’ll cover things like machines and personnel and some of the challenges that we face in implementing these technologies...

What we’re going to talk about is the use of advanced technologies in radiotherapy. And as you know, radiotherapy, 50% of all cancer patients need radiotherapy. It has a very important role both in early and more advanced lung cancer and other types of cancer. So this particular talk is going to look at equity and availability and access, and we’ll cover things like machines and personnel and some of the challenges that we face in implementing these technologies.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...